Literature DB >> 3178777

Hexokinase type I multiplicity in human erythrocytes.

M Magnani1, G Serafini, V Stocchi.   

Abstract

Hexokinase I in human erythrocytes exists in multiple molecular forms that differ in isoelectric points. By means of Western blotting and immunodetection of total glucose-phosphorylating activity by using an antibody raised in rabbit against homogeneous human placenta hexokinase I, a single protein band was detected. Identical results were also obtained by immunoaffinity chromatography of the partially purified enzyme. Separation of the three major hexokinase I subtypes (Ia, Ib and Ic) by h.p.l.c. ion-exchange chromatography and immunodetection following electrophoretic blotting confirmed that each hexokinase subtype showed the same apparent Mr of 112,000, which is the value obtained for the high-Mr hexokinase I from human placenta. Purification of erythrocyte hexokinase by a combination of several procedures including dye-ligand and affinity chromatography that were previously successfully applied to the purification of other mammalian hexokinases type I produced a 35,000-fold-purified enzyme that showed several contaminants after SDS/polyacrylamide-gel electrophoresis. Only one of these peptides was found to be recognized by anti-(hexokinase I) IgG, suggesting that proteolytic degradation does not occur and that hexokinases Ia, Ib and Ic have the same apparent Mr.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178777      PMCID: PMC1135124          DOI: 10.1042/bj2540617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Hexokinase of human erythrocytes. Purification, kinetic model and its application to the conditions in the cell.

Authors:  G Gerber; H Preissler; R Heinrich; S M Rapoport
Journal:  Eur J Biochem       Date:  1974-06-01

3.  Deamidation in vivo of an asparagine residue of rabbit muscle aldolase.

Authors:  C F Midelfort; A H Mehler
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

4.  Purification, properties, and evidence for two subtypes of human placenta hexokinase type I.

Authors:  M Magnani; V Stocchi; G Serafini; L Chiarantini; G Fornaini
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

5.  Separation and characterization of hexokinase I subtypes from human erythrocytes.

Authors:  G Rijksen; G Jansen; R J Kraaijenhagen; M J Van der Vlist; A M Vlug; G E Staal
Journal:  Biochim Biophys Acta       Date:  1981-06-15

6.  Purification and some properties of human erythrocyte hexokinase.

Authors:  G Rijksen; G E Staal
Journal:  Biochim Biophys Acta       Date:  1976-09-14

7.  Isolation and glucose-6-phosphate-mediated dimerization of hexokinase from human heart.

Authors:  A A Haritos; M A Rosemeyer
Journal:  Biochim Biophys Acta       Date:  1985-08-08

8.  Multiple forms of human red blood cell hexokinase. Preparation, characterization, and age dependence.

Authors:  V Stocchi; M Magnani; F Canestrari; M Dachà; G Fornaini
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

9.  Red blood cell glucose metabolism in trisomy 10p: possible role of hexokinase in the erythrocyte.

Authors:  M Magnani; V Stocchi; E Piatti; M Dachà; B Dallapiccola; G Fornaini
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

10.  Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability.

Authors:  M Magnani; V Stocchi; L Cucchiarini; G Novelli; S Lodi; L Isa; G Fornaini
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

View more
  1 in total

1.  Similarities and differences between human and rat hexokinases type I.

Authors:  M Magnani; G Serafini; L Chiarantini; V Stocchi
Journal:  Mol Cell Biochem       Date:  1990-05-10       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.